Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS‐CoV‐2 Omicron wave: a cross‐sectional survey

Author:

Woldegiorgis Mulu12ORCID,Cadby Gemma1,Ngeh Sera1,Korda Rosemary J2,Armstrong Paul K1,Maticevic Jelena1,Knight Paul1,Jardine Andrew3,Bloomfield Lauren E14,Effler Paul V1

Affiliation:

1. Communicable Disease Control Directorate, Western Australia Department of Health Perth WA

2. National Centre for Epidemiology and Population Health Australian National University Canberra ACT

3. Environmental Health Directorate, Western Australia Department of Health Perth WA

4. The University of Notre Dame Australia Fremantle WA

Abstract

AbstractObjectiveTo estimate the prevalence of long COVID among Western Australian adults, a highly vaccinated population whose first major exposure to the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was during the 2022 Omicron wave, and to assess its impact on health service use and return to work or study.Study designFollow‐up survey (completed online or by telephone).Setting, participantsAdult Western Australians surveyed 90 days after positive SARS‐CoV‐2 test results (polymerase chain reaction or rapid antigen testing) during 16 July – 3 August 2022 who had consented to follow‐up contact for research purposes.Main outcome measuresProportion of respondents with long COVID (ie, reporting new or ongoing symptoms or health problems, 90 days after positive SARS‐CoV‐2 test result); proportion with long COVID who sought health care for long COVID‐related symptoms two to three months after infection; proportion who reported not fully returning to previous work or study because of long COVID‐related symptoms.ResultsOf the 70 876 adults with reported SARS‐CoV‐2 infections, 24 024 consented to contact (33.9%); after exclusions, 22 744 people were invited to complete the survey, of whom 11 697 (51.4%) provided complete responses. Our case definition for long COVID was satisfied by 2130 respondents (18.2%). The risk of long COVID was greater for women (v men: adjusted risk ratio [aRR], 1.5; 95% confidence interval [CI], 1.4–1.6) and for people aged 50–69 years (v 18–29 years: aRR, 1.6; 95% CI, 1.4–1.9) or with pre‐existing health conditions (aRR, 1.5; 95% CI, 1.4–1.7), as well as for people who had received two or fewer COVID–19 vaccine doses (v four or more: aRR, 1.4; 95% CI, 1.2–1.8) or three doses (aRR, 1.3; 95% CI, 1.1–1.5). The symptoms most frequently reported by people with long COVID were fatigue (1504, 70.6%) and concentration difficulties (1267, 59.5%). In the month preceding the survey, 814 people had consulted general practitioners (38.2%) and 34 reported being hospitalised (1.6%) with long COVID. Of 1779 respondents with long COVID who had worked or studied before the infection, 318 reported reducing or discontinuing this activity (17.8%).ConclusionNinety days after infection with the Omicron SARS‐CoV‐2 variant, 18.2% of survey respondents reported symptoms consistent with long COVID, of whom 38.7% (7.1% of all survey respondents) sought health care for related health concerns two to three months after the acute infection.

Publisher

Wiley

Reference26 articles.

1. Long COVID after breakthrough SARS-CoV-2 infection

2. Defining long COVID: Going back to the start

3. Centers for Disease Control and Prevention.Long COVID or post‐COVID conditions. Updated 20 July2023.https://www.cdc.gov/coronavirus/2019‐ncov/long‐term‐effects/index.html(viewed June 2022).

4. Long covid—mechanisms, risk factors, and management

5. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3